PET/CT imaging for unclear kidney masses
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests a new imaging agent (68Ga-NYM096) that may help doctors see whether a kidney mass is cancer before surgery. By undergoing a PET/CT scan with this agent, you might help doctors better plan your surgery and avoid unnecessary procedures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You must have a kidney mass that is not yet confirmed as cancer (an 'indeterminate renal mass') seen on a CT or MRI scan, and you must be scheduled to have surgery to remove part or all of that kidney within 3 months after the study imaging.
- You must be generally able to care for yourself (ECOG performance status 0-2).
- Your life expectancy must be at least 6 months.
- If you can become pregnant (or if you are a man), you must agree to use effective birth control during the study and for at least 3 months after the study drug is given.
- You must be able to lie still for the PET scan and not have severe claustrophobia.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new imaging agent that may help doctors see kidney cancer and certain other tumors more clearly on PET/CT scans. It could help find cancer that has spread or come back after treatment.
This trial uses a special PET scan to see if kidney cancer remains or has come back after treatment. The scan helps doctors find cancer cells more precisely, which may guide better treatment decisions.
This trial tests a new PET/CT scan that uses a special tracer to find clear cell kidney cancer. If you are scheduled for kidney tumor removal, this scan may help your surgeon see the cancer more clearly before surgery.
This study tests a special imaging agent (89Zr-TLX250) to help doctors see clear cell kidney cancer during PET/CT scans. It is for people in China who have a single small kidney mass and are already scheduled for surgery to remove it.
This trial tests a new PET scan (a special imaging test) to better grade kidney cancer before surgery. The goal is to see if this scan can help doctors understand how aggressive the cancer is, so they can plan the best treatment for you.
This trial uses a special imaging scan (68Ga-C1 PET/CT) to see kidney cancer more clearly. It helps doctors find and understand clear cell renal cell carcinoma, a common type of kidney cancer.
Hear when a new Clear Cell Renal Cell Carcinoma (ccRCC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.